BriaCell Therapeutics Corp. (BCTXW) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

BriaCell Therapeutics Cor... (BCTXW)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

0.16

-0.02 (-10.41%)

At close: Jan 15, 2025, 3:58 PM

0.16

0.19%

After-hours Jan 15, 2025, 07:17 PM EST

undefined% (undefined)

Bid	0.07
Market Cap	2.93M
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	0
PE Ratio (ttm)	n/a
Forward PE	n/a
Analyst	n/a

Ask	0.24
Volume	279,094
Avg. Volume (20D)	0
Open	0.17
Previous Close	0.18
Day's Range	0.12 - 0.17
52-Week Range	0.12 - 0.17
Beta	undefined

About BCTXW

BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers. The company has a collaboration with Incyte Corpor...

[Show more]

Industry Biotechnology

Sector Healthcare

IPO Date n/a

Employees 16

Stock Exchange NASDAQ

Ticker Symbol BCTXW

Website https://briacell.com

News

No News article available yet